Minutes:
Attending for this item were:
Kath Cobain, Director of Public Health, WCC
Stephanie Courts, Worcestershire Health and Care NHS Trust
Jenny Dalloway, Worcestershire NHS Clinical Commissioning Groups
Sue Harris, Worcestershire Health and Care NHS Trust
Sally-Anne Osbourne, Worcestershire Health and Care NHS Trust
Colleagues had been invited to provide an update on the assessment and diagnostic pathway for children and young people who it was considered were, or may be, on the autistic spectrum. This pathway was known in Worcestershire as the Umbrella Pathway.
The responsibilities of partners were confirmed. The Worcestershire NHS Health and Care Trust (WHCT) was the provider of the service, Worcestershire County Council (WCC) was the commissioner, and funding was provided by the Clinical Commissioning Groups (CCGs).
It was confirmed that the expectation was that support would be provided to families once children were on the pathway.
Members were provided with a presentation and the following main points were made:
· The performance of the service had previously been considered by the Overview and Scrutiny Performance Board in May 2019. At that time, the Board had considered that not enough progress had been made and had requested that the Business Case should be considered by the Children and Families O&S Panel as soon as it was available.
· Since then, the service had been working closely with the Local Authority in relation to the SEND graduated response, which clearly laid out the expectations of all partners and the need to work together.
· This need for partnership working was also a key feature of the NHS Long Term Plan which aimed to stabilise systemic changes.
· The backlog of cases was due to the number of pupils being referred onto the pathway. One aim was to identify those children whose needs were less complex and ‘fast track’ them through the system. This would not be possible for all cases and would depend on the complexities of the child and their family situation.
· The aim was to reduce the backlog by increasing the number of diagnostic meetings.
· Longer term support for children with exceptional needs, including 1-to-1 work, would need to be done in partnership with education colleagues. An example of exceptional need would be a child or young person who was unable to attend school because of anxiety.
· Anxiety workshops had been held recently, delivered by a facilitator with lived experience and these had received positive feedback. Those attending could also be signposted to other support.
· The referral process had been reviewed and now included parental and school questionnaires at the referral stage, additional information which would help at the planning meeting.
· Although it was acknowledged that all cases were complex, those judged to be more straightforward could be fast tracked. The aim was to hold a clinic with two professionals to identify those cases to be fast tracked.
· Diagnostic meetings were multi-disciplinary. These were not attended by parents and may involve discussion of more than one child. The resulting reports were usually shared within two weeks.
· The aim was to implement enhanced referrals in October 2019. Good communications would be key to ensure that referrers understood the additional information that was needed. There was also a need to recruit additional staff. It was important that the clinic had the right professionals in the right setting.
· It was envisaged that from April 2020 no one would spend more than 6 months on the pathway, with exception reporting in place if a case went over this.
· It was confirmed that there were two levels of investment. Firstly, there was investment to clear the backlog of cases. By April 2020 the waiting time from referral to the start of the pathway would be no more than 15 weeks. Secondly, there would be ongoing sustainable investment once the backlog was cleared to continue to find opportunities to reduce waiting times, something that was not a simple process.
· The autism section of the NHS long term plan referred to the need for waiting times to be improved. The aim was to be meeting best practice by 2021/22.
Members were given an opportunity to ask questions and the following main points were raised:
· In response to a question from the Chairman, it was confirmed that support for children with ADHD (Attention Deficit Hyperactivity Disorder) was provided via referral to the Community Paediatric Department where diagnosis would be made and ongoing support provided including medication if necessary.
In conclusion, the Chairman congratulated colleagues on the improvement in the service and the plans for the future outlined in the Business Case. The Panel requested a further update in the second half of 2020 once the new service model had been implemented.
Supporting documents: